Cadrenal Therapeutics Inc. Common Stock
CVKD | NASDAQ
$1.08
-$0.01 (-0.92%)
Sep 22, 2026, 11:49 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 |
|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | 1.27K |
Gross Profit | n/a | n/a | n/a | -1.27K |
Operating Income | -13.46M | -10.96M | -7.63M | -2.7M |
Interest Income | 223.82K | 309.25K | 249.09K | n/a |
Pretax Income | -13.24M | -10.65M | -8.36M | -6.71M |
Net Income | -13.24M | -10.65M | -8.36M | -6.71M |
Selling & General & Admin | 9.35M | 6.75M | 3.55M | 2.31M |
Research & Development | 4.1M | 4.21M | 4.08M | 392.86K |
Other Expenses | 6.87K | 1.88K | 1.98K | n/a |
Operating Expenses | 13.46M | 10.96M | 7.63M | 2.7M |
Interest Expense | n/a | n/a | 17.1K | 107.11K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 13.46M | 10.96M | 7.63M | 2.7M |
Income Tax Expense | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.99M | 1.22M | 868.18K | 775.64K |
Shares Outstanding (Diluted) | 1.99M | 1.22M | 868.18K | 775.64K |
EPS (Basic) | -6.64 | -8.73 | -9.63 | -8.66 |
EPS (Diluted) | -6.64 | -8.73 | -9.63 | -8.66 |
EBITDA | -13.23M | -10.65M | -8.34M | -6.61M |
EBIT | -13.24M | -10.65M | -8.34M | -6.61M |
Depreciation & Amortization | 6.87K | 1.88K | 1.98K | 1.27K |
Add to Watchlist
Select watchlists to add or remove CVKD